Literature DB >> 25733374

Editorial: leukocyte-targeting toxins as therapeutics in allergic asthma.

Namit Sharma1, Andrew W B Craig2.   

Abstract

Entities:  

Keywords:  airway remodelling; allergy; integrins

Mesh：

Substances：

Year:  2015        PMID： 25733374      PMCID： PMC5477893          DOI： 10.1189/jlb.3CE1014-462R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN： 0741-5400            Impact factor:   4.962


× No keyword cloud information.
  10 in total

Review 1.  Functional insights on the polarized redistribution of leukocyte integrins and their ligands during leukocyte migration and immune interactions.

Authors:  Olga Barreiro; Hortensia de la Fuente; María Mittelbrunn; Francisco Sánchez-Madrid
Journal:  Immunol Rev       Date:  2007-08       Impact factor: 12.988

2.  Monoclonal antibodies and progressive multifocal leukoencephalopathy.

Authors:  Joseph R Berger; Sidney A Houff; Eugene O Major
Journal:  MAbs       Date:  2009 Nov-Dec       Impact factor: 5.857

3.  Expression and targeting of lymphocyte function-associated antigen 1 (LFA-1) on white blood cells for treatment of allergic asthma.

Authors:  Anukriti Gupta; Vanessa Espinosa; Lindsey E Galusha; Vahid Rahimian; Katie L Miro; Amariliz Rivera-Medina; Chinnaswamy Kasinathan; Eugenio Capitle; Helen A Aguila; Scott C Kachlany
Journal:  J Leukoc Biol       Date:  2014-10-23       Impact factor: 4.962

4.  In vitro synergism between LFA-1 targeting leukotoxin (Leukothera™) and standard chemotherapeutic agents in leukemia cells.

Authors:  Anukriti Gupta; Amy Le; Benjamin A Belinka; Scott C Kachlany
Journal:  Leuk Res       Date:  2011-06-12       Impact factor: 3.156

5.  Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model.

Authors:  Karin Stenderup; Cecilia Rosada; Thomas N Dam; Erica Salerno; Benjamin A Belinka; Scott C Kachlany
Journal:  J Invest Dermatol       Date:  2011-06-09       Impact factor: 8.551

Review 6.  Aggregatibacter actinomycetemcomitans leukotoxin: from threat to therapy.

Authors:  S C Kachlany
Journal:  J Dent Res       Date:  2010-03-03       Impact factor: 6.116

Review 7.  Asthma heterogeneity and therapeutic options from the clinic to the bench.

Authors:  Tracey L Bonfield; Kristie R Ross
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-02

Review 8.  Understanding asthma pathophysiology.

Authors:  Philip Fireman
Journal:  Allergy Asthma Proc       Date:  2003 Mar-Apr       Impact factor: 2.587

9.  Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients.

Authors:  P Gosset; I Tillie-Leblond; A Janin; C H Marquette; M C Copin; B Wallaert; A B Tonnel
Journal:  Int Arch Allergy Immunol       Date:  1995-01       Impact factor: 2.749

Review 10.  Refractory asthma: mechanisms, targets, and therapy.

Authors:  J L Trevor; J S Deshane
Journal:  Allergy       Date:  2014-04-29       Impact factor: 13.146
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.